Vitamin D deficiency may be a risk factor for OAG

Article

Vitamin D deficiency may be a potential risk factor in the development of open-angle glaucoma (OAG), according to a recent study.

Vitamin D deficiency may be a potential risk factor in the development of open-angle glaucoma (OAG), according to a study recently published In Public Health Nutrition, which is the first to show an association between vitamin D status and OAG.

Researchers from the Yonsei University College of Medicine, Seoul, Republic of Korea, used data from 6,094 adult subjects randomly selected from 192 surveys in 131 locations in South Korea, from the Fifth Korean National Health and Nutrition Examination Survey conducted in 2010–2011. Using multivariate logistic regression, they examined the relationship between serum 25-hydroxyvitamin D [25(OH)D] and OAG after adjusting for traditional potential confounders. OAG was defined using the criteria of the International Society for Geographical and Epidemiological Ophthalmology.

The multivariate-adjusted odds ratio of OAG across quintiles of decreasing 25(OH)D were 1.26 (1.00 reference), 1.31 and 1.69 (P for quadratic trend P

These researchers concluded that there is a reverse J-shaped association between 25(OH)D levels and the risk of OAG, and that subjects with lower 25(OH)D levels had a significantly elevated risks of OAG.

For more information on this study, please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.